Point72 (Difc) LTD Celldex Therapeutics, Inc. Transaction History
Point72 (Difc) LTD
- $2.81 Trillion
- Q2 2024
A detailed history of Point72 (Difc) LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 6,998 shares of CLDX stock, worth $183,417. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,998
Previous 11,230
37.68%
Holding current value
$183,417
Previous $471 Million
45.05%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
64.1MCall Options Held
212KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$212 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$98 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$88.8 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$87.2 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.23B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...